All companies
Ossdsign logo

What smart money is saying about OssdsignSweden flag

OSSD.ST · Healthcare · Medical - Devices · Market cap $134M

1 fund in our archive has pitched Ossdsign — most recently Protean Funds in June 2025.

Company profile

OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.

Get an email when a fund writes about it

Summarize with Warren AI
1
Reported positions
0
Bought
0
Sold
2
Letters

Position history

Between Q2 2025 and Q2 2026, 1 fund letter reported a position in Ossdsign, with no move described.

Fund letters reporting a position in Ossdsign, by quarter
QuarterLettersBoughtSoldTheses
Q2 20261000
Q2 20250001

Fund activity · 1 position

  • HoldsProtean Funds Partner Letter
    April 2026
    and a position in OssDsign which reported so-so figures during what hopefully is a transition phase.
    Read the letterOssdsign

Fund coverage · 1 thesis

  • Protean Funds
    June 2025

    Ossdsign is a promising Swedish medtech company with strong growth potential, evidenced by encouraging one-year fusion rates of 88% for its nanosynthetic bone graft used in spinal fusion surgeries.

    Read the full thesis

Read every full thesis on Ossdsign

Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans
Share this ledger